Aequorin Technology Would Strengthen Leadership Position in GPCR Screening BOSTON–PerkinElmer, Inc. (NYSE: PKI – News), a global technology leader in Health Sciences and Photonics, today announced it signed an agreement with Euroscreen S.A., entitling it to acquire Euroscreen S.A.’s majority owned subsidiary, Euroscreen Products S.A., in a cash transaction. Based in Gosselies, Belgium, Euroscreen Products […]
AUSTIN, Texas and TORONTO, Ontario, Dec. 14 — Luminex Corporation (Nasdaq: LMNX – News) and Tm Bioscience Corporation (TSX: TMC – News) today announced a definitive agreement for Luminex to acquire Tm Bioscience Corporation (TSX: TMC – News), a leader in the commercial genetic testing market. Under the terms of the agreement, each Tm Bioscience […]
November 17, 2006, IJsselstein/Hyderabad – Ocimum Biosolutions, a leading provider of laboratory information management systems (LIMS), bioinformatics solutions, Microarrays and contract research headquartered in Hyderabad, India, has acquired the BioMolecules synthesis business of Isogen Life Science based in The Netherlands. Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said “We are very pleased to have taken […]
SAN DIEGO & HAYWARD, Calif.–Illumina, Inc. (NASDAQ: ILMN – News) and Solexa, Inc. (NASDAQ: SLXA – News) announced today that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger agreement, which was unanimously approved by the Boards of Directors of both companies, Solexa’s […]
VENLO, The Netherlands, October 30, 2006 – QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the world’s premier supplier of solutions for preanalytical sample preparation, today announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. (Genaco). Genaco is an early-stage company applying a proprietary […]
EAST RUTHERFORD, N.J., Oct. 24 — Cambrex Corporation (“Cambrex”) (NYSE: CBM) today announced that it has entered into a definitive stock purchase agreement with Lonza Group AG (“Lonza”) (SWX: LONN) for the sale of the businesses that comprise its Bioproducts and Biopharma segments (“Bio Businesses”), for total cash consideration of $460 million. The Company expects […]
Lonza Group, the global life sciences company, today announces an agreement with Cambrex Corporation (NYSE: CBM) to purchase its Research Bioproducts business and its Microbial Biopharmaceutical business for a cash consideration of US$ 460 million. In conjunction with the planned Initial Public Offering of Polynt S.p.A., these acquisitions will accelerate the group’s strategic development and […]
HERCULES, CA – October 16, 2006 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the acquisition of Blackhawk BioSystems, Inc., a San Ramon, California, based manufacturer of quality control products for use in laboratories that perform […]
Companies Will Provide Integrated Customer and Technical Support to Canadian Customers LA JOLLA, Calif.–Stratagene Corporation (NASDAQ:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostics products, announced today that VWR International, Inc. will become a distributor of Stratagene’s full line of research products in Canada. The companies expect that customers will be […]
September 21, 2006 – Takara Bio, Inc. (Shiga, Japan) announced today that they have entered into a license agreement with Applied Biosystems Group, an Applera Corporation business, under the expanded Applied Biosystems PCR (polymerase chain reaction) licensing program. The expanded program includes patents for real-time PCR and other important PCR-related technologies not licensed under the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
